Cervical
The trials listed below are accepting new patients. Interested patients can Email the coordinator by clicking on envelope icon. Please include a phone number and best times to call.
Treatment stage |
Protocol Title |
ClinicalTrials.Gov Link |
Penn Research Coordinator |
Am I Eligible? |
|---|---|---|---|---|
| Recurrent |
MYTHIC: Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors |
NCT4855656 | Andrea Standish, RN | Eligibility Criteria |
| Recurrent | ATRN: A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors | NCT04905914 | Andrea Standish, RN | Eligibility Criteria |
| Recurrent | Xencor: A Phase 2 Study of XmAb®20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer | NCT05032040 | Isabel Forbes | Eligibility Criteria |
| Recurrent | NP-G2-044-P2-01: NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies | NCT05023486 | Shavon Rochester | Eligibility Criteria |
| Primary Radiation |
GynWPProton: Whole Pelvis Proton Radiation for Gynecologic Cancer |
NCT05758688 | Kelly Clark | Eligibility Criteria |
| Surgery | GOG 3043: A Randomized Controlled Trial of Robotic versus Open Radical Hysterectomy for Cervical Cancer (ROCC trial) |
NCT04831580 | Destany Fields | Eligibility Criteria |